Have a personal or library account? Click to login
Low bone mineral density in Thai children with systemic lupus erythematosus: prevalence and risk factors Cover

Low bone mineral density in Thai children with systemic lupus erythematosus: prevalence and risk factors

Open Access
|Oct 2021

References

  1. Rosenberg AM. Systemic lupus erythematosus in children. Springer Semin Immunopathol. 1994; 16:261–79.
  2. Tarr T, Dérfalvi B, Győri N, Szántó A, Siminszky Z, Malik A, et al. Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus. 2015; 24:796–3.
  3. Amaral B, Murphy G, Ioannou Y, Isenberg DA. A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus. Rheumatology (Oxford). 2014; 53:1130–5.
  4. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol. 1997; 24:1922–9.
  5. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol. 2001; 28:102–8.
  6. Bultink IEM, Lems WF, Kostense PJ, Dijkmans BAC, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum. 2005; 52:2044–50.
  7. Trapani S, Civinini R, Ermini M, Paci E, Falcini F. Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 1998; 18:45–9.
  8. Lilleby V, Lien G, Frøslie KF, Haugen M, Flatø B, Førre Ø. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2005; 52:2051–9.
  9. Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum. 2007; 56:1966–73.
  10. Sambrook P, Cooper C. Osteoporosis. Lancet. 2006; 367(9527):2010–8.
  11. Boot AM, de Ridder MAJ van der Sluis IM, van Slobbe I, Krenning EP, Keizer-Schrama SMPF. Peak bone mineral density, lean body mass and fractures. Bone. 2010; 46:336–41.
  12. Lane NE. Therapy insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006; 2:562–9.
  13. Lilleby V. Bone status in juvenile systemic lupus erythematosus. Lupus. 2007; 16:580–6.
  14. Sarinho ESC, Melo VMPP. Glucocorticoid-induced bone disease: mechanism and importance in pediatric practice. Rev Paul Pediatr. 2017; 35:207–15. [Article in Portuguese, English].
  15. Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, et al. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom. 2014; 17:225–42.
  16. Bachrach LK, Gordon CM; Section on Endocrinology. Bone densitometry in children and adolescents. Pediatrics. 2016; 138:e20162398. doi: 10.1542/peds.2016-2398.
  17. Gordon CM, Leonard MB, Zemel BS; International Society for Clinical Densitometry. 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom. 2014; 17:219–24.
  18. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007; 18:1033–46.
  19. Bishop N, Arundel P, Clark E, Dimitri P, Farr J, Jones G, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions. J Clin Densitom. 2014; 17:275–80.
  20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40:1725. doi: 10.1002/art.1780400928.
  21. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147:573–7.
  22. Binkovitz LA, Henwood MJ. Pediatric DXA: technique and interpretation. Pediatr Radiol. 2007; 37:21–31.
  23. Alsufyani KA, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Nadel H, Malleson PM. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. J Rheumatol. 2005; 32:729–33.
  24. Regio PL, Bonfá E, Takayama L, Pereira RMR. The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus. Lupus. 2008; 17:787–92.
  25. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int. 2002; 13:777–87.
  26. De Nijs RNJ. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. Minerva Med. 2008; 99:23–43.
  27. Castro TC, Terreri MT, Szejnfeld VL, Castro CH, Fisberg M, Gabay M, Hilário MOE. Bone mineral density in juvenile systemic lupus nephritis. Braz J Med Biol Res. 2002; 35:1159–63.
DOI: https://doi.org/10.2478/abm-2021-0030 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 245 - 250
Published on: Oct 29, 2021
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2021 Ankanee Chanakul, Suriyaphon Khunrattanaphon, Tawatchai Deekajorndech, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.